参考文献/References:
[1]Ren Y,Cao S,Wu J,et al.Efficacy and reliability of active robotic-assisted total knee arthroplasty compared with conventional total knee arthroplasty:a systematic review and meta-analysis[J].Postgrad Med J,2019,95(1121):125-133.[2]Warren JA,Sundaram K,Anis HK,et al.Have Venous Thromboembolism Rates Decreased in Total Hip and Knee Arthroplasty?[J].J Arthroplasty,2020,35(1):259-264.[3]Anderson DR,Dunbar M,Murnaghan J,et al.Aspirin or Rivaroxaban for VTE Prophylaxis after Hip or Knee Arthroplasty[J].N Engl J Med.2018,378(8):699-707.[4]田伟.中国骨科大手术静脉血栓栓塞症预防指南[J].中华骨科杂志,2016,36(2):65-71.[5]Feng W,Wang X,Huang D,et al.Ranking the efficacy of anticoagulants for the prevention of venous thromboembolism after total hip or knee arthroplasty:A systematic review and a network meta-analysis[J].Pharmacol Res,2021,166:105438.[6]中华医学会骨科学分会创伤骨科学组,中华医学会骨科学分会外固定与肢体重建学组,中国医师协会骨科医师分会创伤专家工作委员会,等.中国创伤骨科患者围手术期静脉血栓栓塞症预防指南（2021）[J].中华创伤骨科杂志,2021,23(3):185-192.[7]Li X,Keshishian A,Hamilton M,et al.Apixaban 5 and 2.5 mg twice-daily versus warfarin for stroke prevention in nonvalvular atrial fibrillation patients:Comparative effectiveness and safety evaluated using a propensity-score-matched approach[J].PLoS One,2018,13(1):e0191722.[8]Byon W,Garonzik S,Boyd RA,et al.Apixaban:A Clinical Pharmacokinetic and Pharmacodynamic Review[J].Clin Pharmacokinet,2019,58(10):1265-1279.[9]Maniscalco P,Caforio M,Imberti D,et al.Apixaban versus enoxaparin in elective major orthopedic surgery: a clinical review[J].Clin Appl Thromb Hemost,2015,21(2):115-119.[10]Ali Hasan M,Azeez Alsaadi M,Tahseen Mehsen J.Effectiveness of apixaban versus enoxaparin in preventing wound complications and deep venous thrombosis following total knee replacement surgery:A retrospective study[J].Int J Clin Pract,2021,75(10):e14552.[11]Jiang H,Meng J,Guo T,et al.Comparison of Apixaban and Low Molecular Weight Heparin in Preventing Deep Venous Thrombosis after Total Knee Arthroplasty in Older Adults[J].Yonsei Med J,2019,60(7):626-632.[12]Richardson SS,Schairer WW,Sculco PK,et al.Comparison of pharmacologic prophylaxis in prevention of venous thromboembolism following total knee arthroplasty[J].Knee,2019,26(2):451-458.[13]Huang Z,Xie X,Li L,et al.Intravenous and Topical Tranexamic Acid Alone Are Superior to Tourniquet Use for Primary Total Knee Arthroplasty:A Prospective, Randomized Controlled Trial[J].J Bone Joint Surg Am,2017,99(24):2053-2061.[14]Abdelmegied WS,Sallam AM,Ahmed MM.Effect of BMI on complications rate,reoperation and functional outcome after Total Knee Arthroplasty,A Systematic Review of Literature[J].QJM,2020,113(Supplement_1).[15]Schmidt K,Krüger K,Langer E,et al.Reversal of apixaban induced alterations in haemostasis by different coagulation factor concentrates in patients after hip or knee replacement surgery[J].Blood Transfus,2019,17(2):157-162.[16]Rooney T,Barrack RL,Clohisy JC,et al.Is Apixaban Safe and Effective for Venous Thromboembolism Prophylaxis After Primary Total Hip and Total Knee Arthroplasties?[J].J Arthroplasty,2021,36(7S):S328-S331.[17]Huang Z,Huang C,Xie J,et al.Analysis of a large data set to identify predictors of blood transfusion in primary total hip and knee arthroplasty[J].Transfusion,2018,58(8):1855-1862.[18]Xie J,Hu Q,Huang Q,et al.Comparison of intravenous versus topical tranexamic acid in primary total hip and knee arthroplasty:An updated meta-analysis[J].Thromb Res,2017,153:28-36.[19]Xie J,Hu Q,Huang Z,et al.Comparison of three routes of administration of tranexamic acid in primary unilateral total knee arthroplasty:Analysis of a national database[J].Thromb Res,2019,173:96-101.[20]Drain NP,Gobao VC,Bertolini DM,et al.Administration of Tranexamic Acid Improves Long-Term Outcomes in Total Knee Arthroplasty[J].J Arthroplasty,2020(6S):S201-S206.
相似文献/References:
[1]庞永华,陈伟南,许科峰,等.TKA应用氨甲环酸后序贯应用两种新型口服抗凝药预防VTE的疗效对比[J].医学信息官方网站,2022,35(09):100.[doi:10.3969/j.issn.1006-1959.2022.09.025]
PANG Yong-hua,CHEN Wei-nan,XU Ke-feng,et al.Comparison of Efficacy of Sequential Application of Two New Oral Anticoagulants in the Prevention of VTE After Application of Tranexamic Acid in TKA[J].Medical Information,2022,35(15):100.[doi:10.3969/j.issn.1006-1959.2022.09.025]
[2]邹万芹,孙立军.地屈孕酮联合低分子肝素钙治疗先兆流产患者的效果[J].医学信息官方网站,2019,32(14):151.[doi:10.3969/j.issn.1006-1959.2019.14.050]
ZOU Wan-qin,SUN Li-jun.Effect of Dydrogesterone Combined with Low Molecular Weight Heparin Calcium in
Patients with Threatened Abortion[J].Medical Information,2019,32(15):151.[doi:10.3969/j.issn.1006-1959.2019.14.050]
[3]张丽娜,张胜英.低分子肝素钙预防高危产妇剖宫产术后下肢静脉血栓的临床观察[J].医学信息官方网站,2019,32(21):95.[doi:10.3969/j.issn.1006-1959.2019.21.029]
ZHANG Li-na,ZHANG Sheng-ying.Clinical Observation of Low Molecular Weight Heparin Calcium in Prevention of Lower Extremity Venous Thrombosis after High-Risk Maternal Cesarean Section[J].Medical Information,2019,32(15):95.[doi:10.3969/j.issn.1006-1959.2019.21.029]
[4]蔡庆宇,刘海洲.利伐沙班和低分子肝素钙预防中重度脑出血术后下肢深静脉血栓形成的效果比较[J].医学信息官方网站,2021,34(08):150.[doi:10.3969/j.issn.1006-1959.2021.08.040]
CAI Qing-yu,LIU Hai-zhou.Comparison of the Effects of Rivaroxaban and Low-molecular-weight Heparin Calcium in Preventing Deep Vein Thrombosis of Lower Extremities After Moderate to Severe Intracerebral Hemorrhage[J].Medical Information,2021,34(15):150.[doi:10.3969/j.issn.1006-1959.2021.08.040]